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Abstract 
Objectives 
In 2015, the ILAE has issued a new Status epilepticus (SE) classification, including a detailed 
semiological axis. This study assesses frequencies of SE forms in a cohort of adult patients, and 
explores differences and practical implications as compared to a seizure-type-bound 
classification. 
Methods 
The prospective adult SE registry of the CHUV was considered over 5 years (2011-2015); each 
SE episodes was retrospectively reclassified for its semiology according to the new ILAE scheme. 
Mortality rates were retrieved for each subgroup of SE. 
Results 
Among 488 SE episodes, according to the seizure-type-bound classification, 230 (47%) had a 
generalized convulsive, and 29 (6%) a nonconvulsive SE in coma; both categories overlapped 
almost perfectly between the two classifications. However, the 84 episodes with focal SE 
without consciousness impairment and the 141 episodes with consciousness impairment were 
each translated into 2 major (and 5 sub-) categories of the new ILAE classification, having 
markedly different mortality rates. Also, of 140 episodes labeled as focal motor SE according to 
the new classification, 54% had concomitant consciousness impairment, while 46% not; again, 
mortality rates were heterogeneous. 
Significance 
While generalized convulsive and nonconvulsive SE in coma show an almost perfect 
correspondence across SE semiological classifications, focal SE is markedly heterogeneous and 
appears to be better reflected in the new classification, offering more clinically relevant 
subdivisions, also differing in mortality rates. This refined knowledge may allow designing more 
precise clinical prognostic scores than existing tools, and should be taken into account for 
epidemiological studies.  
Key points 
• Focal SE, regardless of related consciousness impairment, represents a markedly 
heterogenous condition, also in terms of mortality rate.  
• Future epidemiological studies should report both classifications to allow comparisons 
with previous findings.  
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• The new ILAE SE classification should include a modifier for consciousness impairment 
for the item “A.3. Focal motor”.  
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Introduction 
Status epilepticus (SE) represents one of the most frequent neurological emergencies with 
potentially fatal outcome 1, 2; over the last decade, increasing attention has been devoted to its 
clinical management 3-6 and outcome prediction 7, 8. Seizure type or semiology during a given SE 
episode represents not only a prognostic predictor 7, but may also be used to orient the 
treatment flow.   
The current therapeutic guidelines in Europe 5 and North America 4 use a relatively simple 
classification derived from the ILAE seizure classifications of 25-35 years ago 9, 10, mainly 
dichotomizing SE into convulsive and nonconvulsive (including absence, focal with impaired 
consciousness or complex partial 11, and subtle 12 or nonconvulsive SE in coma). Of note, this 
type of classification was not developed, nor was it endorsed by the ILAE. In fact, in the ILAE 
classification SE was relegated to the addendum 10, where it was defined as a “seizure that 
persist for a sufficient length of time, or is repeated frequently enough that recovery between 
attacks does not occur”. It was subdivided to partial (i.e. Jacksonian) or generalized, and when 
“very focal” referred to “epilepsia partialis continua”.  In 2001, the ILAE glossary of terms 13 
defined SE as “a seizure that shows no clinical signs of arresting after a duration encompassing 
the great majority of seizures of that type in most patients or recurrent seizures without 
interictal resumption of baseline central nervous system function”. The Core Group of the 
Commission on Classification and Terminology of the ILAE included SE in a list of seizure types, 
which was far from complete 14. Neither the SE classification of 1981, nor its modifications from 
2001 and 2006 were widely accepted and used by the clinical community, which instead 
developed a dichotomized classification (convulsive vs. non convulsive SE), as described above 
4, 5, 15. However, the ILAE recognized the fact that SE cannot be adequately described according 
to “seizures” alone, and therefore a new SE definition and classification has recently been 
proposed by the Task force on Classification of Status Epilepticus 16. In the new classification, 
seizure semiology is the first of four axes (completed by etiology, EEG features, and age), and 
represents the cardinal feature of this approach. While the primary dichotomy is between 
5 
 
prominent motor symptoms and nonconvulsive forms, the taxonomy also includes the level of 
impairment of consciousness (comatose vs. non comatose).  
Given that to the best of our knowledge no practical assessment has been conducted using the 
new ILAE classification, is still unclear how this compares with previous classifications used for 
example in current therapeutic guidelines. The aim of this study was to assess the frequencies 
of SE forms in a large cohort of adult patients, and to explore differences and practical 
implications of these two clinical classifications.   
 
Methods 
We analyzed the SE registry of the Lausanne University Hospital (CHUV), which is approved by 
the Institutional review board (given its purely observational character, patients’ consent are 
not needed) for the period between January 2011 and December 2015. Convulsive (tonic-
clonic) SE was defined as the occurrence of continuous or repetitive seizures without complete 
recovery of baseline clinical conditions for ≥5 min 17. The registry has been described in detail 
previously 18, 19; for each SE episode managed in the CHUV in patients over 16 years, excluding 
postanoxic etiologies, demographical and clinical items are entered prospectively since 2006 by 
physicians of the EEG/epilepsy unit (supervised by AOR and JN) and a study nurse working on 
the project since 2010 (CS); this assures a high internal validity and coherence over the years. In 
particular, the worst seizure type at each episode onset (i.e.: up to treatment start) was 
prospectively assessed according to direct observation or the reports of consulting physicians 
and emergency teams, and classified into the following order of increasing severity (according 
to 10 : absence, focal without consciousness impairment or simple-partial, myoclonic in genetic 
generalized epilepsy; focal with consciousness impairment or complex-partial; generalized 
convulsive; nonconvulsive in coma (including subtle myoclonic movements), as seen in Table 1, 
left column. In November-December 2015, CS and AOR reclassified with the help of patients’ 
charts each episode until 2011 according to the newer ILAE guidelines, as shown in Table 2, left 
column 16; discrepancies were resolved by discussion. Etiologies were considered as potentially 
fatal, as previously described 18, 19, if leading to death without a specific treatment. The 
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validated Status Epilepticus Severity Score (STESS) was calculated upon admission and used to 
stratify episodes according to their gravity. 20, 21 
 Frequencies of SE episodes and the relative mortality rates were described according to the 
two classifications. Furthermore, in order to explore in more detail the potential heterogeneity 
resulting from the comparisons, episodes previously classified as “Focal with consciousness 
impairment” were further detailed in the newer taxonomy, as were episode newly labeled as 
“A.3 Focal motor” towards the previous clinical classification (i.e., including information about 
consciousness impairment). Differences in important SE outcome predictors (such as age, 
occurrence of potentially fatal etiologies and STESS) between focal with- and without 
consciousness impairment (among repetitive focal seizures) were explored using the t-test, χ2, 
or the Mann-Whitney-U-test, as needed. 
 
Results 
Over the five considered years, 488 consecutive SE episodes (230 women; median age 66 years, 
range 16 – 93) occurring in 417 patients were retrieved; there were 64 deaths, accounting for a 
mortality rate of 15.3%. Thirty-one episodes (6%) lasted <30 minutes, only 4 of them labeled as 
focal SE with impaired consciousness (and none of absence SE). 
Table 1 shows the frequencies according to the previous clinical classification; while absence SE 
resulted extremely infrequent, and myoclonic SE was not observed, generalized convulsive SE 
represented almost half of the episodes, focal SE with consciousness impairment (complex-
partial) accounted for slightly more than 1/4, and focal without consciousness impairment just 
over 1/6; finally, nonconvulsive SE in coma occurred in 6%. Mortality was highest in the latter 
group, followed by focal with, focal without consciousness impairment, and generalized 
convulsive forms. 
Table 2 illustrates the breakdown of semiological features according to the newer ILAE 
classification. Convulsive SE as a group (A.1) perfectly reflected generalized convulsive SE in the 
traditional classification and was also the most prevalent form, followed by focal motor SE 
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(A.3), which accounted for almost 30% of episodes. Nonconvulsive SE without coma (B.2) 
occurred in 1/6 of episodes. Finally, nonconvulsive SE with coma (B.1) almost completely 
overlapped with the synonymous form in the older classification; just one patient was scored as 
myoclonic SE in coma. Of note, there were no episodes of tonic, hyperkinetic and 
nonconvulsive SE of autonomic expression without coma.  
From the viewpoint of the previous clinical classification, focal SE was translated into several 
categories of the new taxonomy. As illustrated in Figure 1A, for focal SE without impaired 
consciousness, repeated focal motor seizures (A.3.a) accounted for 60%, followed by 
nonconvulsive SE without coma, aphasic SE (B.2.b.b., 17%) and epilepsia partialis continua 
(A.3.b, 14%). The latter, as opposed to the two previous categories, was not associated with any 
mortality. For focal SE with consciousness impairment, as seen in Figure 1b, the two most 
frequent translations were into repeated focal motor seizures (A.3.a), and nonconvulsive SE 
without coma but impaired consciousness (B2.b.c); this again was mirrored by relevant 
mortality rate differences. Also, focal motor SE in the new ILAE classification and its subgroups 
corresponded to both focal with or without consciousness impairment (complex partial, 
respectively simple partial) SE in an almost balanced way (Table 3), showing again important 
differences in related case-fatality rates. These were explored looking at differences of 
important SE outcome predictors: among repetitive focal motor seizures, patients having focal 
SE with consciousness impairment were significantly older (p=0.026, t-test), had a 
nonsignificant higher STESS (p=0.086, Mann-Whitney), and a comparable frequency of 
potentially fatal etiologies (p=0.847, χ2) as compared to patients with focal SE without 
consciousness impairment.  
 
Discussion 
This study shows that some features, such as focal SE with (complex-partial) or without 
consciousness impairment (simple-partial) of the previous clinical classification, and focal motor 
SE of the new ILAE classification, are markedly heterogeneous and can hardly be directly 
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translated into each other. Conversely, (generalized) convulsive SE and nonconvulsive SE in 
coma almost perfectly overlap. 
The present hospital-based cohort, collected over a five-year period, represents a large sample 
of SE episodes in adults, not restricted to intensive care units. Under-ascertainment seems 
extremely unlikely, given that at the CHUV every adult patient with SE has an EEG, and that 
recruitment was conducted by the EEG/epilepsy unit; furthermore, the internal validity of the 
cohort is strengthened by the work of a restricted team of clinical researchers over the years. 
As a comparison, population-based studies show markedly divergent numbers, with mortality 
rates oscillating between 7% and 26%, and generalized convulsive SE occurring between 33% 
and 74%, with only about 1% of nonconvulsive SE in coma 22-25. More recent hospital-based 
series also show a heterogeneous situation: generalized convulsive SE was observed between 
22% and 60%, and nonconvulsive SE in coma between 4% and 29%; mortality rates were 
estimated between 10% and 24% 26-29. These discrepancies are probably due not only to 
different definitions and assessments as it may be postulated for SE semiology, but also to 
population-specific factors, as it emerges from the short-term case-fatality rates (a non-
debatable outcome): indeed, as an example, studies focusing on ICU populations or carried out 
in Virginia tended to have a higher mortality, while those including children showed reduced 
risks. 
While the lack of myoclonic and tonic SE probably reflects the present cohort characteristics, 
without a relevant prevalence of patients with marked mental retardation and teenagers with 
juvenile myoclonic epilepsy, the lack of hypermotor SE is probably due to the striking rarity of 
this semiology. Some of these forms may also be “masked” by other more severe seizures, the 
episodes being eventually classified according the worst seizure type. 
In the present cohort, focal SE with impairment of consciousness showed a higher mortality 
rate than generalized-convulsive SE. This somewhat unexpected finding may be explained by 
the marked heterogeneity of the former condition. Indeed, mortality rates in focal SE without 
(simple-partial) and with consciousness impairment (complex-partial) were clearly 
inhomogeneous across the corresponding new ILAE classification subgroups: 10-26% for 
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aphasic SE and repeated focal motor seizures, 12 % for focal dyscognitive SE, and <10% for 
other forms, such as epilepsia partialis continua, ictal paresis, adversive SE, and aura continua 
(B.2.b.a). These differences may reflect divergent biological substrates (see below), and in our 
view, this clearly highlights both the major heterogeneity of the term “nonconvulsive SE”, 
which in some assessments 24 may even include SE in coma (a condition with the highest risk of 
mortality), and the usefulness of the new, more detailed SE semiological classification. Similar 
thoughts, however, also apply to the newer category of focal motor SE, where the 
heterogeneity is even found within given subcategories: repeated focal motor seizures and ictal 
paresis unfortunately lack a subcategory informing upon consciousness impairment. In fact, 
patients with repeated focal motor seizures and focal SE with consciousness impairment had a 
clearly higher mortality as compared to those without consciousness impairment, which 
correlated with older age and (to a lesser extent) higher STESS, two robust SE mortality 
predictors.   
Currently, few prognostic scores have been validated in SE, the most widely used being 
probably the STESS, a validated scale including an item on semiology 20, 21, 26. As the present 
study shows, however, a uniform translation into the new classification is challenging, and the 
heterogeneity might account for some of the imprecision of this score, especially regarding 
focal SE. More recently, the EMSE score was proposed, which does not take into account 
seizure types 27; this might represent an advantage for assessing patients studied according to 
different SE classifications; however, the EMSE might prove more difficult to obtain on a clinical 
basis within a short time. It is to hope that a refined use of the new ILAE classification, taking 
into account the aforementioned issues, may contribute designing more precise prognostic 
tools. 
This study has some limitations. Being a single-center cohort, its generalizability is not 
straightforward. However, as detailed above, clinical SE features, including mortality, lie within 
the vast majority of recently published data from the Western world, and, more importantly, it 
reflects a very large, non-selected adult population. While the prospective assessment of SE 
semiology supports the quality of data ascertainment, the retrospective reclassification 
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according to the new ILAE recommendations may have introduced some errors. This was 
conducted within a short time frame by 2 (CS, AOR) authors, using the same criteria: while we 
cannot exclude a systematic error, it is highly unlikely that a non-systematic bias was at play. 
While the registry uses a uniform SE definition threshold at 5 minutes, the ILAE classification 
suggests 10-15 minutes for complex-partial and absence SE; since SE lasting <30 minutes 
occurred in only 4/145 of SE episodes of these both types, this likely did not result in a marked 
bias. Finally, we labeled seizures as the “worst” type at onset of a given episode. While this 
approach has been repeatedly used 7, 19, 29, it admittedly represents a simplification of the 
natural history: it has been recently shown that generalized convulsive seizures evolving 
towards complex-partial at the time of treatment initiation behave clinically rather like 
episodes starting as complex-partial SE 18. A more sequential classification accounting for 
semiological changes over time may better reflect these aspects, but seems rather unpractical 
in a clinical registry and for the purpose of epidemiological studies. 
The described frequency of SE types should be confirmed in a prospective cohort. In any case, 
however, an adaptation of prognostic scores including semiology will be needed. Moreover, 
while future epidemiological studies on SE should definitely use the new ILAE classification, it 
seems highly reasonable to also maintain the old labels, at least for nonconvulsive SE with or 
without consciousness impairment, in order to allow comparisons with previous data.  Finally, it 
is advisable to include a modifier of “consciousness impairment” into item A.3 “Focal  motor 
SE”. 
 
Disclosure of Conflict of Interest 
Dr Rossetti and Prof. Trinka served in the ILAE task force that generated the new SE 
classification. The other authors do not have any conflict of interest in relationship with this 
study.  
 
Required statement 
Our work described here is consistent with the Journal’s guidelines for ethical publication.  
11 
 
Table 1, semiology of each Status epilepticus episode according to the previous clinical classification. 
SE Type Frequency  
(column percentage) 
Mortality related to episodes 
(row percentage) 
Absence 4 (0.8%) 0 (0%) 
Focal without consciousness impairment 84 (17.2%) 7 (8.3%) 
Myoclonic (in idiopathic generalized epilepsy) 0 0 
Focal with consciousness impairment 141 (28.9%) 28 (19.9%) 
Generalized convulsive 230 (47.1%) 17 (7.4%) 
Non-convulsive SE in coma 29 (5.9%) 12 (41.4%) 
Total 488 64  
 
Table 2, semiology of each Status epilepticus episode according to the ILAE classification 16. 
SE Type Frequency 
(column percentage) 
Mortality related to episodes 
(row percentage) 
 New classif. Old classif. New classif. Old classif. 
With prominent motor signs  
A.1 Convulsive SE  
A.1.a Generalized convulsive 134 (27.5%) 
230 (47.1%) 
Generalised 
convulsive 
8 (5.9%) 
17 (7.4%) 
Generalised 
convulsive 
A.1.b Focal evolving into bilateral convulsive 75 (15.4%) 4 (5.3%) 
A.1.c Convulsive unknown if initially focal or 
generalized 21 (4.3%) 5 (23.8%) 
A.2. Myoclonic SE  
A.2.a Myoclonic with coma  1 (0.2%) 1 (0.2%) 
Myoclonic 
0 (0%) 0 (0%) 
Myoclonic A.2.b Myoclonic without coma 0 0 
A.3 Focal motor SE  
A.3.a Repeated focal motor seizures 124 (25.4%) 
142 (29.1%) 
Simple/complex 
Partial 
24 (19.4%) 
24 (16.9%) 
Simple/complex 
Partial 
A.3.b Epilepsia partialis continua 12 (2.5%) 0 (0%) 
A.3.c Adversive 2 (0.4%) 0 (0%) 
A.3.d Oculoclonic 0 0 
A.3.e Ictal paresis 4 (0.8%) 0 (0%) 
A.4 Tonic SE 0 0 0 0 
A.5 Hyperkinetic SE 0 0 0 0 
Without prominent motor signs     
B.1 Nonconvulsive SE with coma 28 (5.7%) 28 (5.7%) 12 (42.9%) 12 (42.9%) 
B2 Nonconvulsive SE without coma  
B.2.a Nonconvulsive SE without coma, 
generalized 4 (0.8%) 4 (0.8%) 0 (0%) 0 (0%) 
B.2.b.a Nonconvulsive SE without coma, 
focal without consciousness impairment 4 (0.8%) 
83 (17.0%) 
Simple/complex 
Partial 
0 (0%) 
11 (13.3%) 
Simple/complex 
Partial 
B.2.b.b Nonconvulsive SE without coma, 
aphasic  28 (5.7%) 5 (17.9%) 
B.2.b.c Nonconvulsive SE without coma, 
focal with consciousness impairment 51 (10.5%) 6 (11.8%) 
B.2.c Nonconvulsive SE without coma, 
autonomic 0 0 0 0 
Total 488 488 64 64 
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Table 3, distribution of focal motor Status epilepticus and its sub- items of the ILAE classification, 
according to the previous clinical classification. 
SE Type 
 
Frequency Mortality Frequency 
(row 
percentage) 
Mortality 
(line 
percentage) 
Age  
mean 
(±SD) 
Potentially 
fatal 
etiology 
STESS 
median 
(range) 
A.3.a Repeated 
focal motor seizures 
124 24 
(19.4%) 
73 CP (58.9%) 19 (26.0%) 67.3 
(±16.0) 
46 (63%) 2 (0-5) 
51 SP (41.1%) 5 (9.8%) 60.6 
(±17.3) 
33 (65%) 2 (0-4) 
A.3.b Epilepsia 
partialis continua 
12 0 (0%) 12 SP (100%) 0 (0%) 44.2 
(±14.1) 
1 (8%) 0 (0-2) 
A.3.c Adversive 2 0 (0%) 2 CP (100%) 0 (0%) 57.0 2 (100%) 2.5 (1-4) 
A.3.d Oculoclonic 0 NA  NA NA NA NA NA 
A.3.e Ictal paresis 4 0 (0%) 1 CP (25%) 0 (0%) 68.0 0 0%) 2 
3 SP (75%) 0 (0%) 48.0  
(±21.5) 
0 (0%) 0 (0-0) 
CP = complex partial (focal with consciousness impairment); SP = simple partial (focal without consciousness 
impairment). STESSS= Status Epilepticus Severity Score. 
 
Figure 1: 
a: distribution of the categories according to the new classification corresponding to focal SE without 
consciousness impairment (simple partial) in the old classification. Mortality rate was 8.3% in simple 
partial SE according the old classification and 14.2% for nonconvulsive w/o coma, aphasic status 
(B.2.b.b), 10% for repeated focal motor seizures (A.3.a), and 0% for all other categories epilepsia 
partialis continua [A.3.b], ictal paresis [A.3.e], nonconvulsive w/o coma, focal without consciousness 
impairment [B.2.b.a]). 
b: distribution of the categories according to the new classification corresponding to focal SE with 
consciousness impairment (complex partial) in the old classification. Mortality rate was 19.9% for 
complex partial SE according the old classification, whereas for repeated focal motor seizures (A.3.a) it 
was 26%, 21.4% for nonconvulsive SE w/o coma, focal with consciousness impairment (B.2.b.c ),  11.7% 
for nonconvulsive SE w/o coma, focal with consciousness impairment (B.2.b.c); and no patient with 
adversive (A.3.c) or ictal paresis (A.3.e) died. 
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